Information Provided By: 
Fly News Breaks for October 23, 2018
IQV
Oct 23, 2018 | 08:20 EDT
RBC Capital analyst George Hill raised his price target on Iqvia to $137 and kept his Outperform rating after its Q3 earnings came in at the high end of guidance with higher outlook for earnings expected in FY18. The analyst adds that the most encouraging development was the management's maintained view of the company's next-gen clinical trials solution selling well as well as its expected R&D revenue growth closing the "gap with bookings" by the end of 2019.
News For IQV From the Last 2 Days
There are no results for your query IQV
